HomeMarket NewsSABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024

SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024

Daily Market Recaps (no fluff)

always free

SABS stock - SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024

Source: iQoncept / Shutterstock

SAB Biotherapeutics (NASDAQ:SABS) just reported results for the first quarter of 2024.

  • SAB Biotherapeutics reported earnings per share of -54 cents. This was below the analyst estimate for EPS of -46 cents.
  • The company reported revenue of $944,575.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/sabs-stock-earnings-sab-biotherapeutics-for-q1-of-2024/.

©2024 InvestorPlace Media, LLC

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.